These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Kidney function in endangiitis obliterans; a contribution to the problem of generalization of endangiitis obliterans and of endanglitis hypertension]. HOLLE F; CARSTENSEN G Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1957; 285(4):397-419. PubMed ID: 13526317 [No Abstract] [Full Text] [Related]
26. Cardiocirculatory function in renal disease. International workshop. Strasbourg, September 19-21, 1983. Contrib Nephrol; 1984; 41():1-459. PubMed ID: 6525830 [No Abstract] [Full Text] [Related]
27. Endothelial health and diversity in the kidney. Segal MS; Baylis C; Johnson RJ J Am Soc Nephrol; 2006 Feb; 17(2):323-4. PubMed ID: 16434502 [No Abstract] [Full Text] [Related]
28. The metabolic syndrome: an overview. Reisin E; Alpert MA Am J Med Sci; 2005 Dec; 330(6):263. PubMed ID: 16355008 [No Abstract] [Full Text] [Related]
29. Endothelin in health and disease. Nakas-Ićindić E; Zaciragić A; Hadzović A; Avdagić N Bosn J Basic Med Sci; 2004 Jul; 4(3):31-4. PubMed ID: 15629009 [TBL] [Abstract][Full Text] [Related]
30. Copeptin: a biomarker of cardiovascular and renal function. Morgenthaler NG Congest Heart Fail; 2010 Jul; 16 Suppl 1():S37-44. PubMed ID: 20653710 [TBL] [Abstract][Full Text] [Related]
31. Asymptomatic hyperuricemia: perhaps not so benign? Neogi T J Rheumatol; 2008 May; 35(5):734-7. PubMed ID: 18464314 [No Abstract] [Full Text] [Related]
32. [Cardiorenal interactions: clinical implication and role in pathogenesis of cardiovascular and renal diseases]. Mukhin NA; Moiseev VS; Kobalava ZhD; Moiseev SV; Fomin VV Ter Arkh; 2004; 76(6):39-46. PubMed ID: 15332575 [No Abstract] [Full Text] [Related]
35. Special Issue on "Frontier Biomechanical Challenges in Cardiovascular Physiopathology". Pasta S; Zingales M Med Eng Phys; 2017 Sep; 47():1. PubMed ID: 28800897 [No Abstract] [Full Text] [Related]
36. [The bicycle ergometry test in the functional assessment of the cardiovascular system and kidneys]. Glezer GA; Moskalenko NP; Glezer MG Kardiologiia; 1993; 33(7):39-45. PubMed ID: 8309180 [No Abstract] [Full Text] [Related]
38. 'Examine my kidneys and my heart': linking renal and cardiovascular disease. Tietge UJ Curr Opin Lipidol; 2017 Feb; 28(1):83-84. PubMed ID: 28030454 [No Abstract] [Full Text] [Related]
39. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. Weinberg MS; Weinberg AJ; Zappe DH J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029 [No Abstract] [Full Text] [Related]
40. I've heard that heart disease and kidney disease are related, but how exactly? Is it that kidney problems can cause heart problems in a person with a relatively healthy heart, or is it that heart disease can lead to kidney disease in someone with healthy kidneys? Heart Advis; 2011 Jan; 14(1):12. PubMed ID: 22973603 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]